Catalyst Wire Dossier Catalyst Wire Dossier

Apydan Extent

oxcarbazepine extended-release · Desitin Arzneimittel GmbH
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Apydan Extent, covering 2013-03-01 to 2013-03-01. Get the full timeline:

Most recent: Clinical Trial Update: ESOXC-ER Efficacy and Safety of an Extended Release (ER) Formulation of Oxcarbazepine (Apydan Extent) in Epileptic Patients

See pricing